GSK’s Arexvy authorised by MHRA
10th July 2023 Uncategorised 0Therapy is the first respiratory syncytial virus vaccine specifically developed for older adults More: GSK’s Arexvy authorised by MHRA Source: News
read moreTherapy is the first respiratory syncytial virus vaccine specifically developed for older adults More: GSK’s Arexvy authorised by MHRA Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals